Surgical management of the head and neck cancer patient following concomitant multimodality therapy

Laryngoscope. 1995 Jan;105(1):97-101. doi: 10.1288/00005537-199501000-00021.

Abstract

The simultaneous use of chemotherapy and radiotherapy (concomitant therapy) has exceptional promise in the treatment of head and neck cancer. In this limited review, seven head and neck cancer patients who underwent prior concomitant therapy and subsequent surgery developed wound-healing complications that were delayed (22-day average) in onset. Paranasal sinus and base of skull operations had less significant wound morbidity than those cases requiring simultaneous transgression of the neck and upper aerodigestive tract. The use of arterialized flaps did not in itself prevent wound breakdown. The formation of controlled fistulae, delay of reconstruction, and avoidance of simultaneous neck and upper aerodigestive tract entry are important considerations in avoiding wound-healing complications after concomitant therapy. In this select group of patients, surgery should be approached with extreme caution and conservatism.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Arteries
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery
  • Combined Modality Therapy
  • Cutaneous Fistula / etiology
  • Female
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / radiotherapy
  • Head and Neck Neoplasms / surgery*
  • Humans
  • Laryngeal Neoplasms / surgery
  • Male
  • Middle Aged
  • Mouth Neoplasms / surgery
  • Paranasal Sinus Neoplasms / surgery
  • Patient Selection
  • Postoperative Complications
  • Salvage Therapy
  • Skull Neoplasms / surgery
  • Surgical Flaps / methods
  • Surgical Flaps / pathology
  • Wound Healing